181 related articles for article (PubMed ID: 32151790)
1. Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner G; Reitsamer R; Urbański B; Kopp P; Murawa D; Adamczyk B; Karzcewska A; Milecki P; Hager E; Reiland J; Ciabattoni A; Matuschek C; Budach W; Nowell K; Schumacher C; Ricke A; Fusco V; Vidali C; Alessandro M; Ivaldi GB; Ziegler I; Fussl C; Zehentmayr F; Grambozov B; Sir A; Hitzl W; Ricardi U; Sedlmayer F
Radiother Oncol; 2020 May; 146():136-142. PubMed ID: 32151790
[TBL] [Abstract][Full Text] [Related]
2. Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: A randomized non-inferiority clinical trial.
Fadavi P; Nafissi N; Mahdavi SR; Jafarnejadi B; Javadinia SA
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1376. PubMed ID: 33797199
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).
Fastner G; Reitsamer R; Gaisberger C; Hitzl W; Urbański B; Murawa D; Matuschek C; Budach W; Ciabattoni A; Reiland J; Molnar M; Vidali C; Schumacher C; Sedlmayer F; On Behalf Of The Hiob Trialist Group
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326548
[TBL] [Abstract][Full Text] [Related]
4. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.
Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Santana C; Ospina J; Lara PC
Clin Transl Oncol; 2021 Jan; 23(1):179-182. PubMed ID: 32445034
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated whole breast irradiation after IORT treatment is safe in patients receiving adjuvant chemotherapy.
Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Murias C; Santana C; Ospina J; Lara PC
Clin Transl Oncol; 2021 Dec; 23(12):2579-2583. PubMed ID: 34091868
[TBL] [Abstract][Full Text] [Related]
7. Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women.
Leonardi MC; Cormio CF; Frassoni S; Dicuonzo S; Fodor C; Intra M; Zerella MA; Morra A; Cattani F; Comi S; Fusco N; Zaffaroni M; Galimberti V; Veronesi P; Dellapasqua S; De Lorenzi F; Ivaldi GB; Bagnardi V; Orecchia R; Rojas DP; Jereczek-Fossa BA
Radiother Oncol; 2022 Dec; 177():71-80. PubMed ID: 36377094
[TBL] [Abstract][Full Text] [Related]
8. Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
Franceschini D; Loi M; Chiola I; Arculeo S; Marzo M; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Clin Breast Cancer; 2021 Jun; 21(3):231-238. PubMed ID: 33121891
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
10. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419).
Forster T; Jäkel C; Akbaba S; Krug D; Krempien R; Uhl M; Häfner MF; König L; Koerber SA; Harrabi S; Bernhardt D; Behnisch R; Krisam J; Hennigs A; Sohn C; Heil J; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Jun; 15(1):134. PubMed ID: 32487184
[TBL] [Abstract][Full Text] [Related]
11. Chronic toxicity and long-term outcome in intraoperative electron radiotherapy as boost followed by whole-breast irradiation.
Oses G; Cases C; Valduvieco I; Farrús B; Alonso I; Caparrós X; Mases J; Muñoz-Guglielmetti D; Biete A; Castro C; Escudero E; Molina M; Herreros A; Saez J; Mollà M
Clin Transl Oncol; 2021 Aug; 23(8):1593-1600. PubMed ID: 33534078
[TBL] [Abstract][Full Text] [Related]
12. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
[TBL] [Abstract][Full Text] [Related]
13. Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation.
Jazmati D; Bölke E; Halfmann K; Tamaskovics B; Ruckhäberle E; Fehm T; Hoffmann J; Krug D; Nestle Krämling C; Corradini S; Budach W; Mohrmann S; Haussmann J; Matuschek C
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892894
[TBL] [Abstract][Full Text] [Related]
14. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
Yadav BS; Sharma SC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
[TBL] [Abstract][Full Text] [Related]
15. Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer.
Wong WW; Pockaj BA; Vora SA; Halyard MY; Gray RJ; Schild SE
Breast J; 2014; 20(2):125-30. PubMed ID: 24372873
[TBL] [Abstract][Full Text] [Related]
16. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
[TBL] [Abstract][Full Text] [Related]
17. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
Ghannam AA; Khedr RA
J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
19. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
20. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
